Partial regimen replacement with aripiprazole reduces serum prolactin in patients with a long history of schizophrenia: a prospective open-label study - Partial regimen replacement with aripiprazole reduces serum prolactin in patients with a long history of schizophrenia

Keiko Naono0 个研究点目标入组 30 人开始时间: 2016年3月8日最近更新: 2023年10月17日

适应症

试验速览

The hyperprolactinemia and other clinical conditions could be improved by the partial replacing to ARP, without no side effect.

•Inclusion criteria were a diagnosis of schizophrenia or a diagnosis in the range of schizophrenia (F2) according to the International Classification of Diseases, version 10 (ICD-10) by a psychiatrist.

•Exclusion criteria were: 1) risk factors that could possibly influence prolactin level (e.g., patients with a prolactin-producing tumor or an endocrine disease such as thyroid disease, and pregnant or lactating female patients), 2) lack of study cooperation or unreliable data, and 3) factors that could possibly influence blood glucose level (e.g., patients with diabetes mellitus).

发起方

Keiko Naono